INVESTORS

09/05/2022: eureKING_Prospectus

09/05/2022: eureKING Launch Press Release_English

09/05/2022: eureKING Launch Press Release_Annex_French

10/05/2022: eureKING Results Press Release_English

13/09/2022: SPAC eureKING Obtains the TIBI label and Strengthens Its Status as a Prime Investor for the Creation of a Major Biomanufacturing Player in Europe

30/12/2022: Interim Financial Report For The Six-Month Period Ended September 30, 2022

30/12/2022: Press Release on Interim Financial Report HY 2022 EN

French Version

28/02/2023:Financial report for the period ending December 31st, 2022

28/04/2023: Press Release on Financial Report FY 2022 EN

                         French Version

16/05/2023: Press Release on intention to combine with Skyepharma to build a new European bio-CDMO leader

                         French Version

eureKING

128 rue de la Boétie, 75008 Paris, France

info@eureKING.com

Press Contacts

Image Sept

Leslie Jung-Isenwater/Sergio de la Calle/Florence Coupry

+33 (0)1 53 70 74 70 

eureking@image7@.fr